| Diabetes and cancer: a consensus report E Giovannucci, DM Harlan, MC Archer, RM Bergenstal, SM Gapstur, ... Diabetes care 33 (7), 1674-1685, 2010 | 3502 | 2010 |
| Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study JM Chan, MJ Stampfer, E Giovannucci, PH Gann, J Ma, P Wilkinson, ... Science 279 (5350), 563-566, 1998 | 2686 | 1998 |
| Insulin and insulin-like growth factor signalling in neoplasia M Pollak Nature Reviews Cancer 8 (12), 915-928, 2008 | 2445 | 2008 |
| Circulating concentrations of insulin-like growth factor I and risk of breast cancer SE Hankinson, WC Willett, GA Colditz, DJ Hunter, DS Michaud, B Deroo, ... The Lancet 351 (9113), 1393-1396, 1998 | 2265 | 1998 |
| Insulin-like growth factors and neoplasia MN Pollak, ES Schernhammer, SE Hankinson Nature Reviews Cancer 4 (7), 505-518, 2004 | 1892 | 2004 |
| Metformin improves healthspan and lifespan in mice A Martin-Montalvo, EM Mercken, SJ Mitchell, HH Palacios, PL Mote, ... Nature communications 4 (1), 1-9, 2013 | 1472 | 2013 |
| Metformin: from mechanisms of action to therapies M Foretz, B Guigas, L Bertrand, M Pollak, B Viollet Cell metabolism 20 (6), 953-966, 2014 | 1412 | 2014 |
| Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3 J Ma, MN Pollak, E Giovannucci, JM Chan, Y Tao, CH Hennekens, ... Journal of the National Cancer Institute 91 (7), 620-625, 1999 | 1408 | 1999 |
| Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial JM Nabholtz, A Buzdar, M Pollak, W Harwin, G Burton, A Mangalik, ... Journal of Clinical Oncology 18 (22), 3758-3767, 2000 | 1369 | 2000 |
| Metformin is an AMP kinase–dependent growth inhibitor for breast cancer cells M Zakikhani, R Dowling, IG Fantus, N Sonenberg, M Pollak Cancer research 66 (21), 10269-10273, 2006 | 1338 | 2006 |
| The insulin and insulin-like growth factor receptor family in neoplasia: an update M Pollak Nature Reviews Cancer 12 (3), 159-169, 2012 | 1254 | 2012 |
| Metformin inhibits mammalian target of rapamycin–dependent translation initiation in breast cancer cells RJO Dowling, M Zakikhani, IG Fantus, M Pollak, N Sonenberg Cancer research 67 (22), 10804-10812, 2007 | 1137 | 2007 |
| Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin) Y Lu, X Zi, Y Zhao, D Mascarenhas, M Pollak Journal of the National Cancer Institute 93 (24), 1852-1857, 2001 | 1098 | 2001 |
| mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation M Morita, SP Gravel, V Chénard, K Sikström, L Zheng, T Alain, V Gandin, ... Cell metabolism 18 (5), 698-711, 2013 | 827 | 2013 |
| Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria HR Bridges, AJY Jones, MN Pollak, J Hirst Biochemical Journal 462 (3), 475-487, 2014 | 709 | 2014 |
| Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy O Kucuk, FH Sarkar, W Sakr, Z Djuric, MN Pollak, F Khachik, YW Li, ... Cancer Epidemiology and Prevention Biomarkers 10 (8), 861-868, 2001 | 655 | 2001 |
| Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development JR Mayers, C Wu, CB Clish, P Kraft, ME Torrence, BP Fiske, C Yuan, ... Nature medicine 20 (10), 1193-1198, 2014 | 653 | 2014 |
| eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression L Furic, L Rong, O Larsson, IH Koumakpayi, K Yoshida, A Brueschke, ... Proceedings of the National Academy of Sciences 107 (32), 14134-14139, 2010 | 602 | 2010 |
| Metformin inhibits the senescence‐associated secretory phenotype by interfering with IKK/NF‐κ B activation O Moiseeva, X Deschênes‐Simard, E St‐Germain, S Igelmann, G Huot, ... Aging cell 12 (3), 489-498, 2013 | 575 | 2013 |
| Investigating metformin for cancer prevention and treatment: the end of the beginning MN Pollak Cancer discovery 2 (9), 778-790, 2012 | 570 | 2012 |
